Introduction
============

For over 20 years, patients have used low intensity pulsed ultrasound (LIPUS) as an adjunct treatment to improve bone healing. Based on radiographic outcomes, the US Food and Drug Administration and the UK National Institute for Health and Care Excellence (NICE) have approved LIPUS for fracture healing.[@ref1] [@ref2] Depending on country and device, LIPUS devices currently cost around £1000-4000 (€1170-4700; \$1250-5000). In 2008, 45% of trauma surgeons in Canada prescribed bone stimulators to manage tibia fractures, equally split between LIPUS and electrical stimulation (21% each).[@ref3] In 2006 sales from LIPUS amounted to about \$250m in the US alone.[@ref3] [@ref4]

Within the past seven years, 10 systematic reviews have assessed the effectiveness of LIPUS for bone healing.[@ref5] [@ref6] [@ref7] [@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13] [@ref14] Because existing randomized controlled trials were limited by small sample size, risk of bias, inconsistent results, and failure to cover outcomes important to patients, no review offered definitive conclusions. All reviews identified the need for additional randomized controlled trials. In addition, recent reviews used suboptimal strategies for outcome selection, data synthesis, analysis, and interpretation, leading to potentially misleading conclusions. For instance, the most recent systematic review,[@ref11] published in the top specialty journal for orthopedic surgeons, considered radiographic union a "critically important outcome" and did not assess the effect of LIPUS on the outcomes of pain relief or re-operation, which are important to patients. Their conclusion that "LIPUS treatment effectively reduces the time to radiographic fracture union" is questionable because it is based on the pooled absolute difference in days to healing, which does not account for the large variation in healing time, showed high unexplained heterogeneity (I^2^=94%), and was driven by studies at high risk of bias. This positive conclusion has the potential to expand the already considerable use of a potentially ineffective treatment.

This systematic review is part of the*BMJ* Rapid Recommendations project, a collaborative effort from the MAGIC research and innovation program ([www.magicproject.org](http://www.magicproject.org)) and *BMJ.* The aim of the project is to respond to new potentially practice changing evidence and provide a trustworthy practice guideline in a timely manner.[@ref15] In this case, the publication of the TRUST trial,[@ref16] a multicentre trial that randomized 501 patients with tibia fractures and has cast doubt on the effectiveness of LIPUS, initiated the process. This systematic review informed a parallel guideline published in a multi-layered electronic format on *bmj.com* [@ref17] and MAGICapp (<https://www.magicapp.org/public/guideline/mL6yYj>).

We assessed whether LIPUS, compared with sham device or no device, improved outcomes important to patients and radiographic healing in those with any kind of fracture or osteotomy.

Methods
=======

Guideline panel and patient involvement
---------------------------------------

According to the *BMJ* Rapid Recommendations process,[@ref15] a guideline panel provided critical oversight to the review and identified populations, subgroups, and outcomes of interest. The panel included six content experts (five orthopedic or trauma surgeons and one physiotherapist), six methodologists (four of whom are also front line clinicians), and four patients with personal experience of fractures (one of whom had used LIPUS). All patients received personal training and support to optimize contributions throughout the guideline development process. The members of the patient panel led the interpretation of the results based on what they expected the typical values and preferences of patients to be, as well as the variation between patients.

Information sources
-------------------

We searched Medline, PubMed, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials up to 16 November 2016, using a combination of keywords and MeSH terms for fracture, orthopedic surgical procedures, and ultrasound. Additional searches included trials registries clinicaltrials.gov and isrctn.com. An experienced research librarian designed the search strategies (appendix 1). Two independent reviewers scanned the references from eligible studies, related systematic reviews, and all studies citing eligible randomized controlled trials on Google Scholar.

Study selection
---------------

We included randomized controlled trials that compared LIPUS with a sham device or no device in patients with any type of fracture regardless of location (long bone or other bone), type (fresh fracture, delayed union, non-union, or stress fracture), or clinical management (operative or non-operative). We included any type of osteotomy, including distraction osteogenesis. We excluded trials published only as protocols or abstracts if we were unable to get the final results from investigators.

Two reviewers, independently and in duplicate, screened the titles and abstracts of identified articles and acquired the full text of any article that either reviewer judged to be potentially eligible. They independently applied the eligibility criteria to the full texts and, when consensus could not be reached, resolved disagreements through discussion or adjudication by a third reviewer.

Data collection
---------------

Two reviewers used standardized forms to independently abstract data; they resolved disagreements by discussion or involved a third reviewer when required. Extracted data included characteristics of patients and fractures, clinical management, risk of bias, intervention details, statements about compliance with treatment, and outcomes.

Risk of bias assessment
-----------------------

Two reviewers independently assessed risk of bias using a modified Cochrane risk of bias instrument that includes response options of "definitely or probably yes" (assigned a low risk of bias) or "definitely or probably no" (assigned a high risk of bias), an approach we have previously validated.[@ref18] On the study level, we assessed generation of randomization sequence, concealment of allocation, blinding of patients, caregivers, and outcome reporting (by comparing each publication with its corresponding published protocol, when available). For each outcome within studies, we assessed blinding of outcome assessors, loss to follow-up, and additional limitations. We considered ≥20% loss to follow-up to represent a high risk of bias, unless the investigators performed appropriate sensitivity analyses showing the robustness of the results. We categorized a trial as being at low risk of bias for a particular outcome if we identified no limitation for any risk of bias item. As a post hoc sensitivity analysis, we alternatively considered a more conservative threshold of ≥10% loss to follow-up because the categorization of three trials depended on this criterion (19%,[@ref16] 28%,[@ref19] and 31%[@ref20] loss to follow-up for the outcome radiographic healing).

Outcomes
--------

Patients identified functional recovery (time to return to work and time to full weight bearing), pain reduction, and number of operations for subsequent fracture or related to osteotomy (re-operation for operatively managed fracture and osteotomy) as the most important outcomes for patients considering LIPUS for bone healing. Because many clinicians currently base their management on time to radiographic healing, a surrogate outcome important only insofar as it influences patient experience, the panel requested its inclusion in our review. We extracted all outcomes that fell into these categories as well as adverse effects related to the ultrasound device.

Synthesis of results
--------------------

We pooled treatment effects of LIPUS on similar outcomes across eligible trials, regardless of clinical subgroups, focusing on complete case analysis. We calculated pooled estimates and associated 95% confidence intervals using random effects models for meta-analysis with three or more studies and fixed effects models for meta-analysis with two studies. We examined heterogeneity associated with all pooled analyses using both the χ^2^ test and I^2^ statistic. SAS version 9.4, R version 3.1, and Review Manager 5.3 provided software for the statistical analysis.

For time to event outcomes, we pooled hazard ratios. For studies that did not apply methods of survival analysis, we considered time to event reported as a continuous variable (for example, days to return to work) at the longest follow-up time. We used the relative effect measure ratio of means (mean LIPUS/mean control) to account for the baseline difference in fracture healing depending on type of bone and (such as scaphoid, clavicle, tibia, etc) and fracture or procedure (such as stress fracture or distraction osteogenesis). We pooled the natural logarithm of the ratio of means and presented the results as percentage difference (relative change). For studies that reported the proportion of patients who achieved the event at a specific time point, we calculated risk ratios.

When studies used different instruments to measure the same construct on a continuous scale, we converted all instruments to the most commonly used instrument among studies and then pooled results using the weighted mean difference.[@ref21]

For the outcomes number of subsequent operations and adverse events related to the device, we calculated both risk ratios, which are preferable in case of varying baseline risks, and risk differences, which allow inclusion of studies with zero events in both groups.

In consultation with the expert and patient guideline panel, we prespecified three subgroup hypotheses to explain heterogeneity of effects between studies: LIPUS will show larger effects in studies at high risk of bias; effects will differ based on clinical subgroups; and LIPUS will show larger in studies effects with greater patient compliance. In consultation with the six clinical experts on the parallel guideline panel, we classified eligible randomized controlled trials according to the following five clinical subgroups: operatively managed fresh fractures, non-operatively managed fresh fractures, stress fractures, non-union, and osteotomy (including distraction osteogenesis). Because compliance was inconsistently reported, two reviewers independently categorized trials using response options of "definitely or probably high compliance" or "definitely or probably moderate compliance," using as a guide a definition of high compliance as at least 80% of patients who applied LIPUS for at least 80% of the total time prescribed. We conducted univariable tests of interaction to establish if the effect size from the subgroups differed significantly from each other and, to test independence of subgroup effects, performed multivariable meta-regression in which we included risk of bias (high versus low), compliance with LIPUS treatment (high versus moderate), and clinical subgroups (as above) as independent variables in a single model.

Only one outcome, days to radiographic healing, included enough studies to perform all planned subgroup analysis. We had prespecified in our protocol at least three studies per group. We assessed the credibility of significant subgroup effects using the criteria suggested by Sun and colleagues.[@ref22] Based on the finding that risk of bias seemed to independently explain the high heterogeneity in the outcome days to radiographic healing, we performed subgroup analysis by risk of bias for all outcomes.

The authors and the guideline panel achieved consensus in categorizing the quality of evidence for all reported outcomes as high, moderate, low, or very low using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. In the GRADE approach, randomized controlled trials begin as high quality but can be rated down because of risk of bias, inconsistency, indirectness, imprecision, or publication bias.[@ref23] We considered rating down for inconsistency if the magnitude and direction of effects were dissimilar, the confidence intervals had minimal overlap, the test of heterogeneity was significant, or the I^2^ was high.[@ref24] For outcomes with 10 or more studies, we inspected symmetry of funnel plots and performed Egger's statistical test for publication bias.[@ref25]

To calculate absolute effects, we applied the effect estimate from the meta-analysis to the control arm of the TRUST trial, which enrolled patients with tibia fractures and had the largest sample size of any eligible study that was at low risk of bias. The approach to rating certainty of individual outcomes was fully contextualized---that is, in rating quality about any individual outcome, we took into account the findings on the other outcomes.

Patient involvement
-------------------

Four patient representatives were full members of the guideline and contributed to the selection and prioritization of outcomes, values and preferences assessments, and critical feedback to the protocol for the systematic review and the *BMJ* Rapid Recommendations manuscript.

Results
=======

Search results
--------------

We identified 3849 potentially eligible abstracts, retrieved 42 studies in full text, and found 26 eligible randomized controlled trials (fig 1[](#f1){ref-type="fig"}).[@ref16] [@ref19] [@ref20] [@ref26] [@ref27] [@ref28] [@ref29] [@ref30] [@ref31] [@ref32] [@ref33] [@ref34] [@ref35] [@ref36] [@ref37] [@ref38] [@ref39] [@ref40] [@ref41] [@ref42] [@ref43] [@ref44] [@ref45] [@ref46] [@ref47] [@ref48] [@ref49] [@ref50] Two trials, Handolin and colleagues[@ref32] [@ref33] and Emami and colleagues,[@ref29] [@ref30] provided two publications reporting on the same group of patients. There were no shared patients between the TRUST pilot[@ref26] and the definitive trial.[@ref16] Our registry search yielded four protocols of potentially eligible trials; one was discontinued because of slow recruitment (ISRCTN90844675, personal communication, outcome data not available yet), one manuscript is under peer review (NCT00744861, personal communication: "no difference between the control group and the ultrasound group"), one is completed but unpublished (JPRN-UMIN000002005, no response from investigators), and the last is still ongoing (NCT02383160). Attempts to acquire the full text of another potentially eligible study,[@ref51] reported in a recent systematic review,[@ref11] were unsuccessful.

![**Fig 1** Studies included in review of low intensity pulsed ultrasound compared with control (sham device or no device) for patients with fracture or osteotomy](schs036958.f1){#f1}

Study characteristics
---------------------

Eligible trials enrolled patients with operatively managed fresh fractures (n=7); non-operatively managed fresh fractures (n=6); stress fractures (n=2); non-unions (n=3); and osteotomies (n=8), of which five were distraction osteogenesis (table 1[](#tbl1){ref-type="table"}). Most trials enrolled patients with tibia fractures or osteotomies (n=14). All but two trials applied LIPUS for 20 minutes every day, either for a fixed period or until radiographic healing. Otherwise, one trial applied LIPUS for 15 minutes a day,[@ref36] and another trial for five minutes every second day.[@ref39] Fifteen trials (60%) provided their control group with an inactive device that was indistinguishable from the active LIPUS. Only three trials (12%) were explicitly free from industry funding.[@ref28] [@ref42] [@ref48]

###### 

Characteristics of studies included in review of low intensity pulsed ultrasound for bone healing after fracture

                                     Bone                        Type of fracture/surgery           Open fracture (%)   Management      Women (%)   Mean age (years)   No of randomized patients   Sham device   Dose and duration of LIPUS   Maximum follow-up                       Explicit free of industry funding   
  ---------------------------------- --------------------------- ---------------------------------- ------------------- --------------- ----------- ------------------ --------------------------- ------------- ---------------------------- --------------------------------------- ----------------------------------- -----
  Busse, 2014[@ref26]                Tibia                       Fresh fracture                     27                  Operative       24          40                 23                          28            Yes                          20 min/day to healing^\*^               1 year                              No
  Busse, 2016[@ref16]                Tibia                       Fresh fracture                     23                  Operative       31          40                 250                         251           Yes                          20 min/day to healing^\*^               1 year                              No
  Dudda, 2011[@ref27]                Tibia                       Distraction osteogenesis           NA                  Operative       11          39                 16                          20            No                           20 min/day to healing^\*^               35 weeks                            No
  El-Mowafi, 2005[@ref28]            Tibia                       Distraction osteogenesis           NA                  Operative       0           35                 10                          10            No                           20 min/day to healing^\*^               12 months                           Yes
  Emami 1999[@ref29] [@ref30]        Tibia                       Fresh fracture                     13                  Operative       25          37                 15                          17            Yes                          20 min/day to healing^\*^               20 weeks                            No
  Gan, 2014[@ref31]                  Tibia, fibula, metatarsal   Stress fracture                    0                   Non-operative   83          30                 15                          15            Yes                          20 min/day for 28 days                  12 weeks                            No
  Handolin, 2005a[@ref32] [@ref33]   Lateral malleolus           Fresh fracture                     0                   Operative       47          42                 11                          11            Yes                          20 min/day for 42 days                  12 weeks                            No
  Handolin, 2005b[@ref34]            Lateral malleolus           Fresh fracture                     0                   Operative       56          40                 15                          15            Yes                          20 min/day for 42 days                  18 months                           No
  Heckman 1994[@ref20]               Tibia                       Fresh fracture                     4                   Non-operative   19          33                 48                          49            Yes                          20 min/day to healing^\*^               140 days                            No
  Kamath, 2015[@ref45]               Tibia and femur             Fresh fracture                     0                   Operative       NR          36                 33                          27            No                           20 min/day for 1 month                  16 weeks                            No
  Kristiansen 1997[@ref19]           Distal radius               Fresh fracture                     0                   Non-operative   84          56                 40                          45            Yes                          20 min/day for 70 days                  140 days                            No
  Leung, 2004[@ref35]                Tibia                       Fresh fracture                     47                  Operative       11          35                 16                          14            Yes                          20 min/day for 4 months                 5 months                            No
  Liu, 2014[@ref36]                  Distal radius               Fresh fracture                     NR                  Non-operative   36          67                 41                          40            No                           15 min/day for ≥12 weeks                At least 12 weeks                   No
  Lubbert, 2008[@ref37]              Clavicle                    Fresh fracture                     0                   Non-operative   16          38                 61                          59            Yes                          20 min/day for 28 days                  8 weeks                             No
  Mayr, 2000[@ref38]                 Scaphoid                    Fresh fracture                     0                   Non-operative   17          37                 15                          15            No                           20 min/day to healing^\*^               120 days                            No
  Patel, 2014[@ref39]                Mandible                    Fresh fracture                     NR                  Non-operative   25          15-35              14                          14            No                           5 min qad for 24 days                   5 weeks                             No
  Ricardo, 2006[@ref40]              Scaphoid                    Non-union                          NA                  Operative       0           27                 10                          11            Yes                          20 min/day to healing^\*^               4 years                             No
  Rue, 2004[@ref42]                  Tibia                       Stress fracture                    0                   Non-operative   50          19                 Probably 20                 Probably 20   Yes                          20 min/day to healing^\*^               NR                                  Yes
  Rutten, 2012[@ref41]               Tibia                       Non-union                          0                   Operative       70          41-63              10                          10            Yes                          20 min/day for 5 months                 5 years                             No
  Salem, 2014[@ref43]                Tibia                       Distraction osteogenesis           NA                  Operative       14          30                 12                          9             No                           20 min/day to healing^\*^               NR                                  No
  Schofer, 2010[@ref44]              Tibia                       Non-union                          NA                  Operative       24          44                 51                          50            Yes                          20 min/day for 16 weeks                 16 weeks                            No
  Schortinghuis, 2005[@ref46]        Mandible                    Distraction osteogenesis           NA                  Operative       75          65                 4                           4             Yes                          20 min/day for 4 weeks                  30 months                           No
  Schortinghuis, 2008[@ref47]        Mandible                    Distraction osteogenesis           NA                  Operative       NR          56                 5                           4             Yes                          20 min/day for 6 weeks                  44 months                           No
  Tsumaki, 2004[@ref48]              Tibia                       Distraction osteogenesis           NA                  Operative       81          68                 21 knees                    21 knees      No                           20 min/day to healing^\*^               NR                                  Yes
  Urita, 2013[@ref49]                Ulna and radius             Osteotomy (shortening)             NA                  Operative       63          48                 14                          13            No                           20 min/day to healing^\*^ or 12 weeks   24 weeks                            No
  Zacherl, 2009[@ref50]              Hallux valgus               Osteotomy (deformity correction)   NA                  Operative       85          53                 26 toes                     26 toes       Yes                          20 min/day for 42 days                  1 year                              No

NA=not applicable; NR=not reported; qad=every other day.

\*Until radiographic healing.

Risk of bias
------------

We contacted authors to resolve areas of uncertainty and successfully clarified details in five randomized controlled trials.[@ref32] [@ref33] [@ref35] [@ref37] [@ref40] We considered six trials to be at low risk of bias,[@ref16] [@ref26] [@ref29] [@ref37] [@ref46] [@ref47] and the remaining 20 studies to be at high risk of bias (table 2[](#tbl2){ref-type="table"}). The main limitations were failure to report method for allocation concealment (15 trials), unblinded patients (10 trials), unblinded caregivers or outcome assessors (10 trials), and high or unclear numbers of patients excluded from the analysis (13 trials; table 2[](#tbl2){ref-type="table"}).

###### 

Risk of bias in studies included in review of low intensity pulsed ultrasound for bone healing after fracture

                                     Sequence generation adequate   Concealment of treatment allocation   Patients blinded   Caregivers blinded   Outcome assessors blinded   Outcomes reported as planned (link to protocol)^\*^   No other bias detected   Loss to follow-up (%) for outcome radiographic healing unless specified otherwise
  ---------------------------------- ------------------------------ ------------------------------------- ------------------ -------------------- --------------------------- ----------------------------------------------------- ------------------------ -----------------------------------------------------------------------------------
  Busse, 2014[@ref26]                Yes                            Yes                                   Yes                Yes                  Yes                         Yes                                                   Yes                      2%
  Busse, 2016[@ref16]                Yes                            Yes                                   Yes                Yes                  Yes                         Yes                                                   Yes                      19% for radiographic healing, 11% for return to work, 9% for weight bearing
  Dudda, 2011[@ref27]                Yes                            No                                    No                 No                   No                          Unclear                                               Yes                      Unclear, assumed to be 0
  El-Mowafi, 2005[@ref28]            Yes                            No                                    No                 No                   No                          Unclear                                               Yes                      5%
  Emami 1999[@ref29] [@ref30]        Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      3%
  Gan, 2014[@ref31]                  Yes                            No                                    Yes                Yes                  Yes                         Unclear                                               Yes                      23% (pain)
  Handolin, 2005a[@ref32] [@ref33]   Yes                            No                                    Yes                Yes                  Yes                         Unclear                                               Yes                      5%
  Handolin, 2005b [@ref34]           Yes                            No                                    Yes                Yes                  Yes                         Unclear                                               Yes                      No eligible outcome reported
  Heckman 1994[@ref20]               Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      31%
  Kamath, 2015[@ref45]               Yes                            No                                    No                 No                   Yes                         Unclear                                               Yes                      No eligible outcome reported
  Kristiansen 1997[@ref19]           Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      28%
  Leung, 2004[@ref35]                No^†^                          No^†^ ^‡^                             No^‡^              No^‡^                No^‡^                       Unclear                                               No^§^                    Unclear, assumed to be 0
  Liu, 2014[@ref36]                  Yes                            No                                    No                 No                   Yes                         Unclear                                               No^¶^                    Unclear, assumed to be 0
  Lubbert, 2008[@ref37]              Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      16% (days to return to work)
  Mayr, 2000[@ref38]                 Yes                            No                                    No                 No                   Yes                         Unclear                                               Yes                      0
  Patel, 2014[@ref39]                Yes                            No                                    No                 No                   No                          Unclear                                               Yes                      Unclear, assumed to be 0
  Ricardo, 2006[@ref40]              Yes                            No                                    Yes                Yes                  Yes                         Unclear                                               Yes                      Unclear, assumed to be 0
  Rue, 2004[@ref42]                  Yes                            No                                    Yes                Yes                  Yes                         Unclear                                               Yes                      Unclear, probably 35%
  Rutten, 2012[@ref41]               Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      45%
  Salem, 2014[@ref43]                Yes                            No                                    No                 No                   No                          Unclear                                               Yes                      Unclear, assumed to be 0
  Schofer, 2010[@ref44]              Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               No^\*\*^                 Unclear, assumed to be 0
  Schortinghuis, 2005[@ref46]        Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      0 for subsequent operation
  Schortinghuis, 2008[@ref47]        Yes                            Yes                                   Yes                Yes                  Yes                         Unclear                                               Yes                      0 for subsequent operation
  Tsumaki, 2004[@ref48]              Yes                            Yes                                   No                 No                   No                          Unclear                                               No^††^                   Unclear, assumed to be 0
  Urita, 2013[@ref49]                No^‡‡^                         No                                    No                 No                   Yes                         Unclear                                               Yes                      Unclear, assumed to be 0
  Zacherl, 2009[@ref50]              Yes                            No                                    Yes                Yes                  Yes                         Unclear                                               No^§§^                   Not included in meta-analysis, insufficient reporting^§§^

\*Studies by Busse et al[@ref16] [@ref26] were protocol NCT00667849; for all other studies no protocol published and trial not registered.

†Quasi-randomized based on sequence of admission.

‡Inactive device distinguishable from active device.

§Unadjusted clustering, 30 fractures of 28 patients were randomized.

¶Implausibly narrow confidence intervals.

\*\*Prognostic imbalance: patients with non-union fractures in LIPUS arm were considerably older.

††Bilateral surgery: one tibia randomized to LIPUS and one to no treatment. Correlation of 0.5 assumed in our analysis of days to radiographic healing.

‡‡Used odd-even system for treatment allocation.

§§Randomized 44 patients but analyzed 52 toes, clustering unclear, SDs not reported.

Outcomes
--------

Table 3[](#tbl3){ref-type="table"} summarizes findings of all outcomes. Interactive tables summarizing findings are available online at <https://www.magicapp.org/public/guideline/mL6yYj>.

###### 

GRADE summary of findings in review of low intensity pulsed ultrasound for bone healing after fracture

  Outcome                                                   Study results (95% CI) and measurements                                                                                                                                                     Absolute effect estimates   Quality of evidence   Narrative summary                                        
  --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------- --------------------- ----------------------------------------- -------------- ------------------------------------------------------------------------
  Days to return to work                                    \% difference: 2.7% (−7.7% to 14.3%) in days, lower better. Based on data from 392 patients in 3 studies                                                                                    Mean 200 days               Mean 205 days         5 days later (15 earlier to 20 later)     Moderate^\*^   LIPUS probably has little or no impact on time to return to work
  Days to full weight bearing                               \% Difference: 4.8% (−4.0% to 14.4%) in days, lower better. Based on data from 483 patients in 2 trials at low risk of bias                                                                 Mean 70 days                Mean 73 days          3 days earlier (3 earlier to 10 later)    High           LIPUS has no impact on time to full weight bearing
  Pain reduction. Follow-up 4-6 weeks                       Mean difference: −0.93 (−2.51 to 0.64) 0 to 100 visual analogue scale, lower better, minimal important difference: 10-15. Based on data from 626 patients in 3 trials at low risk of bias   Mean 40                     Mean 39               1 lower (3 lower to 1 higher)             High           LIPUS has no impact on pain reduction
  Subsequent operations. Follow-up 8 weeks-44 months        Risk ratio: 0.80 (0.55 to 1.16). Based on data from 740 patients in 7 studies                                                                                                               160/1000                    128/1000              32 fewer (72 fewer to 26 more)            Moderate^\*^   LIPUS probably has little or no impact on subsequent operation
  Days to radiographic healing                              \% Difference: −1.7% (−11.2% to 8.8%) in days, lower better. Based on data from 483 patients in 3 trials at low risk of bias                                                                Mean 150 days               Mean 147 days         3 days earlier (17 earlier to 13 later)   Moderate^\*^   LIPUS probably has little or no impact on time to radiographic healing
  Adverse effects related to device. Follow-up 5-52 weeks   Risk difference: 0% (−1% to 1%). Based on data from 839 patients in 9 studies                                                                                                               0/1000                      0/1000                0 fewer (10 fewer to 10 more)             High           LIPUS has no impact on adverse effects related to device

\*Because of serious imprecision.

### Functional recovery

Only the TRUST trial assessed time to return to work with a time to event analysis and found no significant effect (hazard ratio 1.11 favoring control, 95% confidence interval 0.82 to 1.50; 343 patients).[@ref16] Three trials assessed the number of days to return to work; the pooled effect was not significant (2.7% later return with LIPUS, 95% confidence interval 7.7% earlier to 14.3% later; I^2^=0%; 392 patients) (fig 2[](#f2){ref-type="fig"}). We found no significant interaction with risk of bias (P=0.86). If we consider an alternative threshold of ≥10% loss to follow-up for assessing risk of attrition bias, all three studies would fall into the category of high risk of bias. Given the consist absence of effects, however, this would not lower our confidence in the result. A fourth trial in patients with delayed union of tibia fracture provided insufficient data for inclusion in meta-analysis (table 2[](#tbl2){ref-type="table"}) but reported no significant difference in days to return to work.[@ref50]

![**Fig 2** Difference in days to return to work after fracture treated with low intensity pulsed ultrasound (LIPUS) compared with control (sham device or no device)](schs036958.f2){#f2}

Only the TRUST trial assessed time to full weight bearing with a time to event analysis and found no significant effect (hazard ratio 0.87 favoring LIPUS, 95% confidence interval 0.70 to 1.08; 451 patients). Three trials assessed the number of days to full weight bearing. Overall results suggested no significant effect on full weight bearing with LIPUS but high heterogeneity (I^2^=95%). The effect of the one trial at high risk of bias (40.0% earlier, 48.4% to 30.3 earlier)[@ref35] differed significantly from the consistent results from the two trials at low risk of bias (4.8% later, 4.0% earlier to 14.4% later; 483 patients; interaction P\<0.001, subgroup effect not effected by alternative threshold for missing data) (fig 3[](#f3){ref-type="fig"}).

![**Fig 3** Difference of days to full weight bearing after fracture treated with low intensity pulsed ultrasound (LIPUS) compared with control (sham device or no device), by risk of bias. Interaction P\<0.001](schs036958.f3){#f3}

Appendix 2 presents results of other functional outcomes including return to leisure activities, return to household activities, return to level of function before injury, and physical function measured with a multidimensional questionnaire. None of these was significantly affected by use of LIPUS, nor did they show substantial inconsistency.

### Pain reduction

Four trials assessed pain, two with a 100 mm visual analogue scale[@ref37] [@ref49] and two with the "bodily pain" subdomain of the SF-36 instrument.[@ref16] [@ref26] After we transformed all results to a 100 mm visual analogue scale, findings at three to six weeks' follow-up showed no significant effect of LIPUS on pain reduction but high heterogeneity (I^2^=97%). The effect of the one trial at high risk of bias (28.12 mm lower, 95% confidence interval 37.05 to 19.19 lower)[@ref39] differed significantly from the consistent results from the three trials at low risk of bias (0.93 mm lower, 2.51 lower to 0.64 higher; 626 patients; I^2^=0%; interaction P\<0.001; fig 4[](#f4){ref-type="fig"}). The subgroup effect was no longer significant when we used a threshold of ≥10% missing data to designate a trial at high risk of attrition bias (P=0.35, fig A in appendix 3). Two other small studies assessed pain intensity at five months but could not be included in the meta-analysis. One reported pain outcomes only narratively (no effect),[@ref41] and another used a modified instrument with unclear scale and variance (no effect).[@ref49]

![**Fig 4** Mean difference of pain reduction after fracture treated with low intensity pulsed ultrasound (LIPUS) compared with control (sham device or no device) by risk of bias. All instruments transformed to 0-100 visual analogue scale. Interaction P\<0.001](schs036958.f4){#f4}

Other outcomes for pain included pain intensity assessed at multiple time points and number of painful days (appendix 4). None showed a significant effect of LIPUS nor substantial inconsistency.

### Number of subsequent operations

Ten trials reported the number of subsequent operations, including three trials reporting zero events in both arms. Neither the pooled risk ratio (0.80 in favor of LIPUS, 95% confidence interval 0.55 to 1.16; I^2^=0%; seven trials, 693 patients; fig 5[](#f5){ref-type="fig"}) nor the pooled risk difference (3% reduction with LIPUS, 7% reduction to 2% increase; I^2^=0%; 10 trials, 740 patients) showed a significant effect. There was no significant interaction with risk of bias on either scale (risk ratio: P=0.75; risk difference: P=0.64). The results did not depend on the threshold for missing data.

![**Fig 5** Risk ratio of number of subsequent operations related to fracture after fracture treated with low intensity pulsed ultrasound (LIPUS) compared with control (sham device or no device)](schs036958.f5){#f5}

### Time to radiographic healing

Two trials used time to event analysis methods to assess time to radiographic healing[@ref16] [@ref26] and showed no significant effect of LIPUS (hazard ratio 1.06 in favor of control, 95% confidence interval 0.86 to 1.32; I^2^=0%; 532 patients). Fifteen trials reported the number of days to radiographic healing. Overall results suggested accelerated radiographic healing with LIPUS (26% earlier, 33.6% to 17.8% earlier; I^2^=85%). The effect differed significantly between the 12 trials at high risk of bias (32.8% earlier, 39.5% to 25.3% days earlier; I^2^=78%; 446 patients) and the three trials at low risk of bias (1.7% earlier, 11.2% earlier to 8.8% later, I^2^=10%; 483 patients; interaction P\<0.001; fig 6[](#f6){ref-type="fig"}). This subgroup effect fulfilled eight of nine credibility criteria relevant to risk of bias as an explanation of heterogeneity (table 4[](#tbl4){ref-type="table"}). In addition, the subgroup effect was robust to our sensitivity analysis using a more conservative threshold for defining risk of attrition bias (interaction P=0.004, fig B in appendix 3). The effect of LIPUS on days to radiographic healing did not differ significantly across clinical subgroups (interaction P=0.13, fig C in appendix 3) or between high and moderate compliance with treatment (interaction P=0.99, fig D in appendix 3). In our multivariable meta-regression, which included risk of bias, clinical subgroups, and compliance with treatment, the only significant effect modifier was the risk of bias (P=0.005).

![**Fig 6** Percentage difference in days to radiographic healing after fracture treated with low intensity pulsed ultrasound (LIPUS) compared with control (sham device or no device), by risk of bias. Interaction P\<0.001](schs036958.f6){#f6}

###### 

Credibility of subgroup effects for risk of bias for outcome days to radiographic healing in studies of low intensity pulsed ultrasound for bone healing

  Criteria[@ref22]                                                                                  Rating (yes means higher credibility)
  ------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  Is subgroup variable a characteristic measured at baseline or after randomization?                Not applicable for risk of bias
  Is effect suggested by comparisons within rather than between studies?                            No, between studies
  Was subgroup effect specified a priori?                                                           Yes, specified in our protocol
  Was direction of subgroup effect specified a priori?                                              Yes, we expected larger effects for studies at high risk of bias
  Is there indirect evidence that supports hypothesized interaction (biological rationale)?         Not applicable for risk of bias
  Was subgroup effect one of a small number of hypothesized effects tested?                         Yes, one of three
  Does interaction test suggest low likelihood that chance explains the apparent subgroup effect?   Yes, significant in univariable subgroup analysis (P\<0.001)
  Is significant subgroup effect independent?                                                       Yes, significant in multivariable meta-regression (P\<0.01)
  Is size of subgroup effect large?                                                                 Yes, 31.8% acceleration in high risk of bias trials versus 1.7% acceleration in low risk of bias trials
  Is interaction consistent across closely related outcomes within study?                           Yes, risk of bias explained heterogeneity in outcomes weight bearing and pain
  Is interaction consistent across studies?                                                         Yes, high risk of bias studies consistently showed large effects, low risk of bias studies small effects

Another randomized controlled trial in patients with delayed union of tibia fracture reported only the proportion of healed fractures at 16 weeks and did not find a significant difference (65% in the LIPUS and 46% in the control arm, P=0.07; high risk of bias towards LIPUS because of serious imbalance in age of fracture at baseline).[@ref44]

The funnel plot based on time to radiographic healing was not clearly asymmetrical, and Egger's test for publication bias was not significant (P=0.25, fig E in appendix 3).

### Adverse effects related to device

Seven studies explicitly reported the absence of any adverse effects related to the device; two other studies reported mild transient skin irritations in six patients. The pooled risk ratio based on these two studies (2.65 in favor of control, 95% confidence interval 0.32 to 22.21; 129 patients) was not significant, nor was the pooled risk difference based on all nine trials (0%, 1% reduction to 1% increase; I^2^=0%; 839 patients; fig 7[](#f7){ref-type="fig"}). We found no significant interaction with risk of bias on the risk difference scale (P=0.75).

![**Fig 7** Risk difference in adverse effects related to ultrasound device after fracture treated with low intensity pulsed ultrasound (LIPUS) compared with control (sham device or no device)](schs036958.f7){#f7}

Discussion
==========

Main findings
-------------

Our systematic review provides moderate quality evidence that LIPUS applied to patients with fractures or osteotomies has no effect on time to return to work or the number of subsequent operations (table 3[](#tbl3){ref-type="table"}). Overall results suggested a possible reduction of days to full weight bearing, pain, and radiographic healing, but with large variability between studies strongly associated with risk of bias as an effect modifier: only trials with high risk of bias showed benefit. Based on randomized controlled trials at low risk of bias, we found high quality evidence that LIPUS has no effect on pain reduction, days to full weight bearing, or adverse effects related to the device, and moderate quality evidence that LIPUS has no effect on days to radiographic healing (table 3[](#tbl3){ref-type="table"}).

Comparison with other systematic reviews
----------------------------------------

Our results are consistent with other systematic reviews in concluding that most randomized controlled trials on LIPUS treatment are poorly reported, lack outcomes important to patients, and are at high risk of bias.[@ref5] [@ref6] [@ref7] [@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13] [@ref14] Our systematic review, however, differs from previous systematic reviews in several important aspects. Firstly, we include the recently published TRUST trial,[@ref16] by far the largest trial on LIPUS treatment for bone healing, which reported a number of outcomes important to patients. Secondly, our choice of outcomes and interpretation of findings were informed by a guideline panel including patients with personal experience of fractures in the context of *BMJ* Rapid Recommendations. Patients considered functional recovery, pain reduction, and operations as critical outcomes, while expressing little interest in the commonly reported surrogate outcome of radiographic healing. Thirdly, we used optimal statistical approaches and, in particular, the ratio of means to combine days to radiographic healing, return to work, or full weight bearing across studies. This relative effect measure is most appropriate in the context of LIPUS, where the average time to recovery differs substantially between clinical subgroups. For instance, a lower grade stress fracture is likely to heal much faster than a complicated tibia fracture. It is not surprising, therefore, that previous meta-analyses found high heterogeneity when they used absolute mean differences to pool across studies.[@ref8] [@ref11] [@ref12]

Finally, we used the GRADE approach to assess the quality of evidence, taking into account the results of subgroup analysis based on risk of bias: when effects differed significantly between high and low quality trials, we based our conclusions on trials at low risk of bias. Our approach of limiting conclusions to trials at low risk of bias depends on our judgment of risk; however, our ratings of risk of bias were consistent with those of a previous Cochrane systematic review.[@ref5] Furthermore, most trials judged to be at high risk of bias had limitations in more than one domain, and some had additional sources of bias including baseline imbalance or unclear clustering when patients had more than one fracture or operation. Application of our risk of bias judgments as an effect modifier met eight of nine relevant criteria for a credible subgroup analysis (table 4[](#tbl4){ref-type="table"}). A post hoc sensitivity analysis exploring a more conservative threshold for attrition bias (≥10% loss to follow-up) yielded, for all outcomes, results essentially consistent with the primary analyses

Limitations
-----------

The primary limitation of our review is the failure of most trials to measure or report outcomes important to patients. Of the 26 eligible trials, 11 reported, in sufficient detail for inclusion in meta-analysis, outcomes that patients consider critical for decision making.[@ref16] [@ref26] [@ref27] [@ref29] [@ref31] [@ref32] [@ref33] [@ref35] [@ref37] [@ref39] [@ref46] [@ref47] Of these, the only four trials that contributed substantial data included either patients with operatively managed fresh tibia fracture[@ref16] [@ref26] [@ref29] or conservatively managed clavicle fracture.[@ref37] One could question the extent to which our results apply to patients not included at all (such as children) or under-represented (stress fractures, non-union, and osteotomies) in the eligible trials. Qualitative subgroup effects (such as no benefit in one subgroup and important benefit in another) are, however, unusual. In the absence of evidence to the contrary, it might therefore be reasonable to apply our results to these populations. Our subgroup analysis and meta-regression for radiographic healing found no effect modification based on clinical subgroups. Certainly, the burden of proof regarding the effect of LIPUS in children and under-represented populations rests with those who might postulate a benefit.

LIPUS compared with electrical stimulation
------------------------------------------

Our findings are similar to those of a 2016 systematic review of 15 small trials that explored electrical stimulation versus sham treatment for fracture healing, only four of which were at low risk of bias.[@ref52] This review found moderate quality evidence for a 35% reduction (95% confidence interval 19% to 47%; I^2^=46%) in the rate of radiographic non-union. The authors found no evidence of a subgroup effect based on clinical presentation (that is, fresh fractures, delayed union or non-union, spinal fusion, or surgical osteotomy; interaction P=0.41). They did not explore whether risk of bias explained heterogeneity, but all four trials at low risk of bias showed no significant effect on radiographic union.[@ref53] [@ref54] [@ref55] [@ref56] They found a small reduction in pain (mean difference of −7.7 mm on a 100 mm visual analogue scale for pain, −13.92 to −1.43) and low quality evidence for no difference in functional outcome (mean difference of −0.88 points on 100 point SF-36 physical component summary score, −6.63 to 4.87).

Conclusions
-----------

In conclusion, moderate to high quality evidence shows that LIPUS fails to accelerate return to work, return to full weight bearing, and pain reduction or reduce the need for subsequent operation. If one gives highest credibility to combined effects from all available randomized controlled trials, low quality evidence would suggest a large reduction in time to radiographic healing. If, however, one gives higher credence to trials at low risk of bias, moderate to high quality evidence suggests that LIPUS not only has no effect on outcomes important to patients but also fails to accelerate radiographic healing. The evidence applies directly to patients with fresh fractures. The applicability to children and other under-represented populations, particularly those with non-union, for which no trustworthy direct evidence exists, is open to debate.

### Linked articles in this *BMJ*Rapid Recommendations cluster

1.  • Poolman RW, Agoritsas T, Siemieniuk RAC, et al. Low intensity pulsed ultrasound (LIPUS) for bone healing: a clinical practice guideline. *BMJ*2017;356:j576. doi:[10.1136/bmj.j576](10.1136/bmj.j576)

    1.  summary of the results from the Rapid Recommendation process

2.  Magic App ([www.magicapp.org](http://www.magicapp.org/))

    1.  expanded version of the results with multilayered recommendations, evidence summaries, and decision aids for use on all devices

### What is already known on this topic

1.  Low intensity pulsed ultrasound (LIPUS) devices are marketed worldwide to accelerate recovery from a fracture or osteotomy

2.  Previous systematic reviews provided no definite conclusions about the effect of LIPUS on outcomes important to patients and radiographic healing

### What this study adds

1.  A guideline panel including patients and clinical experts informed outcome selection, importance of outcomes, subgroup analyses, and interpretation of results

2.  Subgroup analyses suggested that beneficial effects of LIPUS are restricted to trials at high risk of bias

3.  With inclusion of the recently published TRUST trial, sufficient high quality data for patients with fresh fractures has accumulated to conclude that LIPUS fails to improve outcomes important to patients and radiographic healing
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